Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

COPD Exacerbation Blood and Urine Biomarkers Study

NCT03823443 is registered in ClinicalTrials.gov with Columbia University as lead sponsor.

NCT NCT03823443
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03823443 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
COPD Exacerbation Blood and Urine Biomarkers Study
Lead sponsor
Columbia University
Phase
Observational
Overall status
Terminated
Start date
June 7, 2018
Completion date
January 8, 2021
Enrollment
7 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute exacerbation copd, alpha-1 anti-trypsin deficiency, chronic obstructive pulmonary disease